Metanomics

Metanomics Health is a specialized biotechnology company focused on metabolomics-based biomarker discovery and personalized medicine. Originally established as a subsidiary of BASF, the company utilizes advanced mass spectrometry and bioinformatics to provide metabolic profiling services to pharmaceutical and diagnostic partners. Their core technology, the MetaMap platform, assists in understanding drug modes of action, identifying safety biomarkers, and stratifying patient populations in clinical trials. In 2018, Metanomics Health was acquired by Eurofins Scientific, integrating its capabilities into Eurofins' global network of clinical and laboratory services to support drug development and precision medicine.